Clinical Trials

Pancreatic Neoplasms

NCT02024009 2024-07-25

SCALOP-2

159 enrolled

Phase 2 Active not recruiting

Pancreatic Neoplasms

NCT03351296 2024-05-08

BETTER2

140 enrolled

Pancreatic Neoplasms

NCT04371224 2024-04-19

NaliCap

Phase 2 Recruiting

200 enrolled

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pancreatic Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

2 enrolled

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01525082 2024-02-06

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

EndocrineGastrointestinal

20 enrolled 15 charts

Glucagonoma, Insulinoma, Pancreatic Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT03376659 2024-02-05

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Phase 1/2 Terminated

8 enrolled 14 charts

Phase EARLY_PHASE1 Withdrawn

Pancreatic Neoplasms, Colorectal Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT06217042 2024-01-22

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Phase 3 Not yet recruiting

524 enrolled

Pancreatic Neoplasms

NCT06202014 2024-01-19

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

43 enrolled

Pancreatic Neoplasms

NCT05415917 2023-08-22

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

75 enrolled

Pancreatic Neoplasms

NCT01726582 2023-08-14

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

229 enrolled 14 charts

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01845337 2023-05-12

TOFFEE

59 enrolled

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT05566743 2022-10-04

A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

40 enrolled

Pancreatic Neoplasms

NCT01497392 2022-07-22

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

26 enrolled

Pancreatic Neoplasms

NCT02451553 2022-06-07

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

41 enrolled

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT01918644 2022-06-01

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

21 enrolled

Pancreatic Neoplasms

NCT01360593 2022-03-08

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

35 enrolled 18 charts

Pancreatic Neoplasms

NCT01683422 2021-08-10

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Phase NA Terminated

9 enrolled 8 charts

Pancreatic Neoplasms

NCT02368860 2021-06-01

OXIRI

33 enrolled

Pancreatic Neoplasms

NCT01591733 2021-05-28

FOLFIRINOX + RT for Pancreatic Cancer

48 enrolled 16 charts

Pancreatic Neoplasms

NCT01459614 2021-05-19

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

44 enrolled 12 charts

Pancreatic Neoplasms

NCT03959150 2021-04-30

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

Phase 2/3 Unknown

231 enrolled

Pancreatic Neoplasms

NCT01077986 2021-04-21

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

35 enrolled

Pancreatic Neoplasms

NCT01494155 2021-02-02

Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

50 enrolled

Pancreatic Neoplasms

NCT00634751 2019-11-26

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

48 enrolled 13 charts

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT02352831 2019-08-28

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 1/2 Terminated

16 enrolled 15 charts

Pancreatic Neoplasms

NCT00030732 2019-05-15

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

Phase 3 Completed

319 enrolled

Pancreatic Neoplasms

NCT02581501 2019-04-18

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

Phase 1 Withdrawn

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01760252 2019-03-15

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Phase 2 Terminated

17 enrolled

Pancreatic Neoplasms

NCT00438256 2019-01-23

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

50 enrolled 7 charts

Pancreatic Neoplasms

NCT01032057 2018-10-26

SCALOP

114 enrolled

Pancreatic Neoplasms

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Phase 2 Terminated

249 enrolled 4 charts

Pancreatic Neoplasms

NCT00003867 2018-09-10

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

30 enrolled

BreastGastrointestinal

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT01534637 2018-08-15

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

22 enrolled 9 charts

Bile Duct Neoplasms, Nausea, Pancreatic Neoplasms, Vomiting

NCT00408564 2018-07-23

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

39 enrolled 10 charts

Pancreatic Neoplasms

NCT02767752 2018-07-10

CHIPAC

Phase 2 Terminated

21 enrolled